Cold Pain Therapy Market 2020 | Size, Merger and Share | By Products, Applications and End Users Overview Forecast to 2026

Cold pain therapy is a therapeutic application of cold that is used in the treatment of acute soft tissue injuries and to reduce the pain in post-operative condition in orthopedic surgeries, treatment of benign and malignant lesions, and in pain management. Cryotherapy can be applied topically (on the skin surface), surgically or percutaneously. This can also be used to treat various skin conditions such as oral mucositis and tumors in the liver, kidney, bones, breasts and lungs, skin tumors, skin tags, pre-cancerous skin moles, and injuries.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1162

Cryosurgery procedure involves usage of extreme cold such as liquid nitrogen or argon gas to destroy abnormal tissues. According to the National Cancer Institute (NCI), cryosurgery is used for treatment of several types of cancers and some non-cancerous conditions. It is reported to be effective for treatment of early stage skin cancer, retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia. Moreover, according to a study published in the Journal of the National Cancer Institute, in October 2017, it was observed that cryotherapy was effective in controlling the side effects of chemotherapy induced peripheral neuropathy.

According to the U.S. Food & Drug Administration (FDA), cryotherapy is ‘super cooling’ of the body tissues for therapeutic purposes. Moreover, cryotherapy involves use of products such as ice packs on a certain portion of the body such as lower back. Whole Body Cryotherapy (WBC) involves exposure of the body to liquid nitrogen vapors to reach ultra-low temperature ranging from -200 to -300 degrees Fahrenheit. WBC treatment is provided in relatively confined spaces or chamber for two to four minutes. However, the U.S. FDA does not have sufficient evidence to recommend use of WBC to treat disease or conditions such as Alzheimer’s disease, rheumatoid arthritis, stress, multiple sclerosis, anxiety or chronic pain. Use of WBC has various risks such as burns, frostbite, and eye injury from extremely low temperature.

Quick Buy – Cold Pain Therapy Market Research Report: https://bit.ly/2OCKo8T

Increasing prevalence of skin, prostate, retinoblastoma, cervical cancer, and others and increasing rate of accidental and sport injuries are the factors that are expected to drive growth of the cold pain therapy market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), 12,578 women in the U.S. were diagnosed with cervical cancer while 4,115 women in the U.S. died from cervical cancer in 2014. In addition, according to the Cancer Research UK, 3,224 new cases of cervical cancer were reported in 2014, in the U.K., alone.

Moreover, increasing workplace-related injuries and sport injuries are expected to boost growth of the cold pain therapy market. For instance, according to the Health and Safety Executive (HSE), 0.6 million non-fatal injuries at workplace were accounted in 2016. Moreover, new cases of work-related illness in the U.K. accounted for loses of US$ 12.4 billion in 2016. Furthermore, according to the U.S. Bureau of Labor Statistics 2016, around 2.9 million non-fatal workplace injuries and illness were reported by private industry employees in 2016.

Cold Pain Therapy Market Taxonomy:

On the basis of product, cold pain therapy market segmented into:

• OTC-based Products
  • Pharmaceuticals
    • Gels, Ointment, and Creams
    • Patches
    • Spray and Foams
    • Roll-ons
  • Medical Devices
    • Cold Packs
    • Cooling Pads, Wraps, and Pads
• Prescription-based Products
  • • Motorized Cryotherapy Devices
    • Non-motorized Cryotherapy Devices

On the basis of therapy type, cold pain therapy market segmented into:

• Cryosurgery
• Icepack Therapy
• Chamber Therapy

On the basis of device type, cold pain therapy market segmented into:

• Spray Cryogun
• Dipstick Applicator
• Cryoprobe
• Others

On the basis of application, cold pain therapy market segmented into:

• Dermatology
• Oncology
• Musculoskeletal disorder
• Pain management
• Sport medicine
• Physical therapy
• Ophthalmology
• Post-operative
• Post-trauma

On the basis of distribution channel, cold pain therapy market segmented into:

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1162

Recent developments in the cold pain therapy market

In July 2017, CSA Medical, Inc. received the FDA clearance to expand truFreeze catheter offering to include Rapid AV Spray Kit. This system is used in cryosurgical procedures for application in gynecology, dermatology, general surgery, and in the removal of malignant lesions. Moreover, the addition of rapid AV Spray kit with truFreeze catheter is expected to reduce the surgical time thereby, reducing overall patient treatment time.

In January 2017, PENTAX Medical, a company engaged in manufacturing, development and R&D activities in endoscopic product and services acquired the C2 Therapeutics. C2 Therapeutics manufactures C2 CryoBalloon Ablation System for endoscopic ablation of tissue. Moreover, the acquisition enabled PENTAX Medial to strengthen its therapeutic endoscopy products and services portfolio.

Key players in the cold pain therapy market:

Some of the key players in the cold pain therapy market include CryoConcepts LP, Metrum Cryoflex, Brymill Cryogenic Systems, Mectronic Mediccale S.r.l., Sanarus, Wallach Surgical Devices, Zimmer MedizinSystems, CooperSurgical Inc., CSA Medical, Inc., Cortex Technology, Erbe Elektromedizin, GmbH, Special Medical Technology Co., Ltd, Medtronic plc, Galil Medical, Inc., and PHYSIOMED AG.

Table of Content

Global Cold Pain Therapy Market Research Report
Section 1: Global Cold Pain Therapy Industry Overview
Section 2: Global Economic Impact on Cold Pain Therapy Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Cold Pain Therapy Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Cold Pain Therapy Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837